Second Interim and First Molecular Analysis of the EORTC Randomized Phase III Intergroup CATNON Trial on Concurrent and Adjuvant Temozolomide in Anaplastic Glioma Without 1p/19q Codeletion.
Neuro-Oncology(2019)
关键词
MGMT Promoter Methylation,Tumor Heterogeneity
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要